SCHEMBL3213913

SCHEMBL3213913

COCCNCc1ccc2c(c1)nc(C1CCCC(NC(=O)c3ccc4c(c3)OCCO4)C1)n2C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.44
▸ RAB9A P51151 5/20 0.44
▸ ITK Q08881 2/20 0.40
▸ SMYD3 Q9H7B4 1/20 0.40
▸ CHRNA7 P36544 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ ACHE P22303 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ P2RY13 Q9BPV8 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ TP53 P04637 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ MAPK11 Q15759 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13490337 0.94 NPC1 (0.44) NPC1RAB9ASMYD3CHRNA7ALDH1A1
SCHEMBL3214906 0.94 NPC1 (0.44) NPC1RAB9ASMYD3CHRNA7ALDH1A1
SCHEMBL3202564 0.89 NPC1 (0.48) NPC1RAB9ACHRNA7ALDH1A1HPGD
SCHEMBL13490431 0.88 NPC1 (0.48) NPC1RAB9ASMYD3CHRNA7ALDH1A1
SCHEMBL3199435 0.88 NPC1 (0.48) NPC1RAB9ACHRNA7ALDH1A1HPGD
Hydrochloric Acid SCHEMBL3224048 0.87 NPC1 (0.47) NPC1RAB9ASMYD3CHRNA7ALDH1A1
SCHEMBL3210950 0.86 NPC1 (0.46) NPC1RAB9ASMYD3CHRNA7ALDH1A1
SCHEMBL3222668 0.86 NPC1 (0.46) NPC1RAB9ACHRNA7ALDH1A1HPGD
SCHEMBL13490331 0.85 NPC1 (0.46) NPC1RAB9ACHRNA7ALDH1A1HPGD
SCHEMBL3213404 0.85 NPC1 (0.46) NPC1RAB9ACHRNA7ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029615-A1 BENZIMIDAZOLE DERIVATIVES PFIZER INC. 2010-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029615-A1 BENZIMIDAZOLE DERIVATIVES ACIN1, HAT1, CCNE1 NPC1 3250/4885RAB9A 1662/4885ITK 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback